Comorbidities and Cardiovascular Risk Factors in Older Adults Undergoing Anticancer Therapy

Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.

He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy. 

He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.

Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.

He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.

Dr Ishwaria Subbiah, is a medical oncologist and palliative care physician and serves as the Executive Director, Cancer Care Equity and Professional Wellness at the Sarah Cannon Research Institute as well as the Medical Director, Supportive Care Oncology, Health Equity, and Professional Well-being for The US Oncology Network. In these complementary roles, Dr Subbiah leads the network-wide oncology professional well-being strategy and partners with key teams to enhance symptom management services including palliative care, evidence-based cancer care for older adults, advanced practice provider education, and equity initiatives that broaden clinical trials access across the integrated national cancer care network that cares for 1.4 million people with cancer every year across 250 clinical practices in 24 states with 1,300 oncology physicians. 

Dr Avirup Guha, Assistant Professor at Augusta University, leads Cardio-Oncology at the Medical College of Georgia, Augusta, US. Dr Guha's ongoing research, under the patronage of the American Heart Association and the Department of Defense, delves deep into the translational science concerning biological disparities between White and Black men with prostate cancer (PC) undergoing androgen deprivation therapy (ADT). A key focal point is the exploration of the Nicotinamide Adenine Dinucleotide pathway and its influence on vascular aging, further probing how social determinants of health modify its effects in the mentioned demographic. He is board-certified in cardiology, cardio-oncology, echocardiography, and several other cardiac imaging modalities.